Zhengyu Jiang Selected Research

Zhengyu Jiang Research Topics

Disease

28	Neoplasms (Cancer) 03/2024 - 01/2012
11	Inflammation (Inflammations) 09/2023 - 01/2018
7	Sepsis (Septicemia) 11/2023 - 12/2017
5	Hypoxia (Hypoxemia) 09/2023 - 01/2018
5	Carcinogenesis 01/2020 - 01/2012
3	Fibrosis (Cirrhosis) 01/2024 - 01/2023
3	Endotoxemia 03/2020 - 01/2018
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 11/2018 - 01/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 02/2024 - 02/2023
2	Wounds and Injuries (Trauma) 09/2023 - 11/2022
2	Reperfusion Injury 09/2023 - 01/2023
2	Colitis 05/2023 - 01/2021
2	Hypersensitivity (Allergy) 01/2023 - 10/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2020 - 02/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2015
2	Adenocarcinoma 11/2018 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2012
1	Ureteral Obstruction 01/2024
1	Demyelinating Diseases (Demyelinating Disease) 12/2023
1	Acute Kidney Injury (Acute Renal Failure) 09/2023
1	Necrosis 09/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Pain (Aches) 01/2023
1	Ischemia 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Neuroinflammatory Diseases 01/2023
1	Respiratory Hypersensitivity 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Lung Injury 01/2022
1	Dehydration (Water Stress) 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2021
1	Leukemia 01/2021

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2015
5	CytokinesIBA 01/2024 - 01/2018
5	LipopolysaccharidesIBA 03/2020 - 12/2017
4	Interleukin-6 (Interleukin 6)IBA 09/2023 - 06/2018
4	Messenger RNA (mRNA)IBA 09/2023 - 01/2020
4	Hematoxylin (Haematoxylon)IBA 09/2023 - 11/2022
4	Eosine Yellowish-(YS) (Eosin)IBA 09/2023 - 11/2022
3	Long Noncoding RNAIBA 02/2024 - 01/2012
3	Therapeutic UsesIBA 12/2023 - 11/2020
3	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2023 - 10/2018
3	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2024 - 01/2015
2	Malondialdehyde (Propanedial)IBA 09/2023 - 01/2023
2	CollagenIBA 09/2023 - 01/2023
2	Mitogen-Activated Protein KinasesIBA 09/2023 - 01/2018
2	Dextran SulfateIBA 05/2023 - 01/2021
2	ProdrugsIBA 03/2023 - 11/2020
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2017
2	Adenosine Triphosphatases (ATPase)IBA 10/2021 - 01/2021
2	Histamine AgonistsIBA 01/2021 - 12/2017
2	GastrinsIBA 01/2021 - 01/2020
2	2-5A-dependent ribonuclease (RNase L)IBA 01/2019 - 01/2019
2	Nerve Growth Factors (Neurotrophins)IBA 11/2018 - 01/2018
2	Adrenergic Agents (Adrenergic Drugs)IBA 11/2018 - 01/2018
2	Cholinergic Agents (Cholinergics)IBA 11/2018 - 01/2017
2	Nerve Growth Factor (NGF)IBA 01/2018 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 10/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2024
1	CatalaseIBA 09/2023
1	EnzymesIBA 09/2023
1	Fibronectins (Fibronectin)IBA 09/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2023
1	Caspase 3 (Caspase-3)IBA 09/2023
1	AntioxidantsIBA 09/2023
1	Superoxide Dismutase-1IBA 09/2023
1	Tumor Biomarkers (Tumor Markers)IBA 09/2023
1	cardamoninIBA 09/2023
1	superoxide dismutase 2IBA 09/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 05/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Superoxide DismutaseIBA 01/2023
1	benzocycloheptapyridineIBA 01/2023
1	6-methyladenineIBA 01/2023
1	puerarinIBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	AntibodiesIBA 11/2022
1	MucinsIBA 11/2022
1	Immunoglobulins (Immunoglobulin)IBA 11/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	AllergensIBA 01/2022
1	OvalbuminIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Methylcellulose (BFL)IBA 08/2021
1	venetoclaxIBA 08/2021
1	PotassiumIBA 06/2021
1	AlbuminsIBA 06/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2021

Therapy/Procedure

12	Therapeutics 02/2024 - 01/2015
3	Immunotherapy 03/2024 - 02/2016
2	Critical Care (Surgical Intensive Care) 11/2023 - 06/2021
2	Oral Administration 09/2023 - 01/2021
2	Ligation 11/2022 - 01/2018
2	Punctures 11/2022 - 01/2018
1	Fluid Therapy (Oral Rehydration Therapy) 10/2021